A box of Pulmozyme

Find information on thousands of medical conditions and prescription drugs.

Dornase alfa

Dornase alfa (Pulmozyme®) is a highly purified solution of recombinant human deoxyribonuclease I (rhDNase), an enzyme which selectively cleaves DNA. Pulmozyme hydrolyzes the DNA in sputum/mucus of CF patients and reduces viscoelasticity in the lungs, promoting improved clearance of secretions.

A

B

C

D

Dextromethorphan

Dextropropoxyphene

Diethylcarbamazine

Diethylstilbestrol

Diethyltoluamide

Dihydroergotamine

Dihydrotachysterol

Dimethyl sulfoxide

Dimethyltryptamine

Diphenhydramine

Docusate sodium

Dv

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Read more at Wikipedia.org

• [List your site here Free!]



	Dornase alfa reduces air trapping in children with mild cystic fibrosis lung disease : a quantitative analysis Purpose: To evaluate quantitative air trapping measurements in children with mild cystic fibrosis (CF) lung disease during a 1-year, double-blind, placebo-controlled, ... From CHEST, 10/1/05 by Terry E. Robinson

	Dornase alfa therapy in cystic fibrosis: who should get it? - Editorial Pulmonary disease is the major cause of morbidity and mortality in cystic fibrosis (CF). Soon after birth, thick, viscous secretions accumulate in the ... From CHEST, 10/1/96 by Jamshed F. Kanga

	Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease - Pulmozyme Study Group Study objective: The 12-week efficacy and safety of aerosolized recombinant human DNase (dornase alfa) were evaluated in previously untreated patients ... From CHEST, 10/1/96 by Karen McCoy

	Computed Tomography Correlates with Pulmonary Exacerbations in Children with Cystic Fibrosis Rationale: High-resolution computed tomography (HRCT) has been suggested as a potential outcome surrogate for cystic fibrosis (CF) lung disease. An important ... From American Journal of Respiratory and Critical Care Medicine, 11/1/05 by Brody, Alan S

	Pneumothorax in cystic fibrosis Background: Spontaneous pneumothorax is a complication that is commonly reported in patients with cystic fibrosis (CF). An understanding of the pathophysiology ... From CHEST, 8/1/05 by Patrick A. Flume

	Massive hemoptysis in cystic fibrosis Background: Massive hemoptysis is a complication commonly reported in patients with cystic fibrosis (CF). An understanding of the pathophysiology of ... From CHEST, 8/1/05 by Patrick A. Flume

	Interventions during donor care before lung transplantation Improvement in the ratio of PaO^sub 2^ to the fraction of inspired oxygen and treatment of pulmonary infections in donors have been cited as important ... From Progress in Transplantation, 6/1/05 by Powner, David J

	Device selection and outcomes of aerosol therapy: evidence-based guidelines Background: The proliferation of inhaler devices has resulted in a confusing number of choices for clinicians who are selecting a delivery device for ... From CHEST, 1/1/05 by Myrna B. Dolovich

Home

Contact

Resources

ebay